Advertisement

 

 

Updated Guidelines for NSTE-ACS

Updated Guidelines for NSTE-ACS
Author Information (click to view)

Ezra A. Amsterdam, MD, FACC

Distinguished Professor, Internal Medicine
Associate Chief of Cardiology for Academic Affairs
Master Clinician Educator
University of California, Davis School of Medicine

 

+


Ezra A. Amsterdam, MD, FACC (click to view)

Ezra A. Amsterdam, MD, FACC

Distinguished Professor, Internal Medicine
Associate Chief of Cardiology for Academic Affairs
Master Clinician Educator
University of California, Davis School of Medicine

 

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Recently, the American College of Cardiology and American Heart Association (ACC/AHA) updated their guideline on the management of patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). “This guideline is the first full revision of previous recommendations since 2007,” says Ezra A. Amsterdam, MD, FACC, who co-chaired the ACC/AHA writing committee. The other co-chair was Nanette Wenger, MD, of Emory University, and the writing group included 18 clinicians from multiple specialties involved in the care of patients with NSTE-ACS.

“The ACC/AHA update offers a new name and terminology that reflects current ways of thinking about the condition,” says Dr. Amsterdam. “The terminology now emphasizes the pathophysiologic continuum of unstable angina and NSTEMI and their frequently indistinguishable clinical presentations.” The update incorporates both established and new evidence from published clinical trials and information from basic science and comprehensive review articles. Dr. Amsterdam notes that there have been major advances since 2007 with regard to enhancing the care of these patients. Although still extensive and comprehensive, the document is now more direct and succinct.

Update-Guidelines-NSTE-ACS-Callout

Important Changes

“A significant change in the guideline was to replace the term ‘initial conservative management’ with ‘ischemia-guided strategy,’” says Dr. Amsterdam. “This was done to more clearly convey the physiologic rationale of this approach.” When treating NSTE-ACS, the guideline notes that an early invasive strategy for those with high-risk coronary artery disease has been successful. However, low-risk patients can benefit substantially from guideline-directed medical therapy (GDMT), an approach that has not always been optimally used.

Advances in cardiac troponin testing should help clinicians detect patients with NSTE-ACS, according to Dr. Amsterdam. “Advances in non-invasive assessment of prognostic risk may help distinguish if patients should receive invasive therapy or GDMT,” he says. “The guideline also offers recommendations on management of specific medications, such as triple therapy for stroke prophylaxis, in NSTE-ACS patients who require dual antiplatelet therapy and anticoagulation for atrial fibrillation.” In addition, the ACC/ AHA guidelines recommend developing a plan of care in the post-hospital phase, including information on patient education about symptoms, risk modification, medications, secondary prevention, referral to cardiac rehabilitation, and other GDMT.

Future Research

The guideline writing group reported that several important clinical areas require further investigation. “We need research on the appropriate application of new, high-sensitivity troponins that should be available soon,” Dr. Amsterdam says. “These are much more sensitive than current troponins, and we’ll need to determine how best to use and interpret this new source. We also need more studies on the utility of triple therapy with antithrombotic and anticoagulant drugs and on the proper selection of high-risk elderly patients and women for interventional therapy.”

Readings & Resources (click to view)

Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Sep 23 [Epub ahead of print]. Available at: http://circ.ahajournals.org/content/early/2014/09/22/CIR.0000000000000134.

Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012;126:875-910.

Fihn S, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease. Circulation. 2014 Jul 28 [Epub ahead of print].

January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014 Mar 28 [Epub ahead of print].

O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-425.

Submit a Comment

Your email address will not be published. Required fields are marked *

14 − 6 =

[ HIDE/SHOW ]